The IPO Buzz: Central Bancompany (CBC) Prices NASDAQ Uplisting at $21 – Low End
Missouri-based Central Bancompany (CBC) priced its NASDAQ Uplisting deal at $21.00 – the low end of its $21.00-to-$24.00 price range – and sold 17.8 million shares – the number of shares in the prospectus – to raise $373.38 million in its public offering on Wednesday night, Nov. 19, 2025. This was not an IPO.
Central Bancompany’s uplisting deal was priced after the bell on Wednesday. The pricing followed both “the Dow Jones Industrial Average and the S&P 500 snapping their four-day losing streaks as megacap technology names bounced back ahead of Nvidia earnings,” as MarketWatch reported.
Central Bancompany’s stock is expected to start trading today – Thursday, Nov. 20, 2025 – on the NASDAQ under CBC – its new symbol – in this uplisting from the OTC Market.
At pricing, Central Bancompany had a market cap of $5.0 billion.
Morgan Stanley and Keefe, Bruyette & Woods acted as the lead joint book-runners.
The book-running team included BofA Securities, Piper Sandler and Stephens.
Central Bancompany (CBC), based in Jefferson City, Missouri, is the profitable parent of The Central Trust Bank, a community bank with branches in Missouri, Kansas, Oklahoma, Illinois, Colorado and Florida. Its history goes back to 1902. The banking company is incorporated in Missouri.
Its flagship – The Central Trust Bank – operated a network of 156 full-service branches across 17 MSAs (metropolitan statistical areas) as of June 30, 2025, the prospectus said. Most of its branches are in Missouri and Kansas. Additional branches are located in Oklahoma, Illinois and Colorado – plus one branch in Naples, Florida.
Over the past three years, the company built six new branches to expand its footprint in Oklahoma, Colorado and Florida, and grow its customer base, according to the prospectus. It also “closed three branches in well-served markets,” the prospectus said.
“Over the next few years, we intend to expand our coverage in attractive metro opportunities with eight new branches planned for Greater St. Louis, Kansas City Metro and Denver, CO. On August 14, 2025, we received approval from the Federal Reserve to open a new branch in the Denver, CO MSA,” the prospectus said.
As for dividends: Central Bancompany has a history of paying dividends. Worth Noting: On Oct. 10, 2025, the company announced a quarterly cash dividend on its Class A common stock of $0.155 per share – yes, 15.5 cents per share – payable Dec. 1, 2025, to all holders of record as of October 20, 2025.
Central Bancompany is highly profitable, according to financial statements in the prospectus: Net income of $320.7 million on revenue of $924.8 million for the 12 months that ended June 30, 2025.
(For more information about this company, please check the IPO Calendar and the individual IPO Profile found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.
Source: https://www.iposcoop.com/the-ipo-buzz-central-bancompany-cbc-prices-nasdaq-uplisting-at-21-low-end/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

